rs759920

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001130823.3(DNMT1):​c.649-197T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.512 in 151,940 control chromosomes in the GnomAD database, including 20,149 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 20149 hom., cov: 31)

Consequence

DNMT1
NM_001130823.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.691

Publications

18 publications found
Variant links:
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
  • autosomal dominant cerebellar ataxia, deafness and narcolepsy
    Inheritance: Unknown, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary sensory neuropathy-deafness-dementia syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 19-10174102-A-G is Benign according to our data. Variant chr19-10174102-A-G is described in ClinVar as Benign. ClinVar VariationId is 679318.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.656 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130823.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
NM_001130823.3
MANE Select
c.649-197T>C
intron
N/ANP_001124295.1P26358-2
DNMT1
NM_001318730.2
c.601-197T>C
intron
N/ANP_001305659.1
DNMT1
NM_001379.4
c.601-197T>C
intron
N/ANP_001370.1P26358-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT1
ENST00000359526.9
TSL:1 MANE Select
c.649-197T>C
intron
N/AENSP00000352516.3P26358-2
DNMT1
ENST00000340748.8
TSL:1
c.601-197T>C
intron
N/AENSP00000345739.3P26358-1
DNMT1
ENST00000592705.5
TSL:1
n.*339-197T>C
intron
N/AENSP00000466657.1K7EMU8

Frequencies

GnomAD3 genomes
AF:
0.512
AC:
77691
AN:
151822
Hom.:
20116
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.515
Gnomad AMI
AF:
0.559
Gnomad AMR
AF:
0.490
Gnomad ASJ
AF:
0.554
Gnomad EAS
AF:
0.674
Gnomad SAS
AF:
0.548
Gnomad FIN
AF:
0.516
Gnomad MID
AF:
0.551
Gnomad NFE
AF:
0.497
Gnomad OTH
AF:
0.488
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.512
AC:
77788
AN:
151940
Hom.:
20149
Cov.:
31
AF XY:
0.513
AC XY:
38107
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.515
AC:
21332
AN:
41402
American (AMR)
AF:
0.491
AC:
7472
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.554
AC:
1921
AN:
3468
East Asian (EAS)
AF:
0.674
AC:
3483
AN:
5164
South Asian (SAS)
AF:
0.547
AC:
2642
AN:
4830
European-Finnish (FIN)
AF:
0.516
AC:
5453
AN:
10560
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.497
AC:
33781
AN:
67970
Other (OTH)
AF:
0.492
AC:
1038
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1941
3882
5822
7763
9704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
706
1412
2118
2824
3530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.406
Hom.:
1568
Bravo
AF:
0.506
Asia WGS
AF:
0.606
AC:
2105
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.2
DANN
Benign
0.65
PhyloP100
-0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759920; hg19: chr19-10284778; COSMIC: COSV61584146; COSMIC: COSV61584146; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.